Medicare Enrolled
Dr. Sumit Mahajan, MD
Internal Medicine · Yucca Valley, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mahajan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mahajan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mahajan
Dr. Sumit Mahajan is an internal medicine specialist in Yucca Valley, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mahajan performed 2,889 Medicare services across 1,530 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mahajan received a total of $5,059 from 36 pharmaceutical and/or device companies across 212 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mahajan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 11% volume in CA
$5,059 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,889
Medicare services
Top 11% in CA for internal medicine
1,530
Unique beneficiaries
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~144 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
721 | $90 | $157 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
633 | $5 | $15 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
436 | $62 | $105 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
237 | $56 | $100 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
182 | $42 | $100 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
179 | $133 | $300 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
104 | $72 | $125 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
87 | $138 | $200 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
50 | $41 | $112 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
46 | $54 | $190 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
46 | $37 | $100 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
35 | $96 | $151 |
| Nursing facility visit, established patient, straightforward A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes. |
34 | $26 | $75 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
24 | $47 | $157 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
23 | $110 | $212 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
20 | $85 | $280 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
20 | $256 | $350 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
12 | $228 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,059
Total received (2018-2024)
Avg $723/year across 7 years
Top 16% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
212
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,964 (98.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$95 (1.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$678
2023
$775
2022
$738
2021
$847
2020
$41
2019
$916
2018
$1,064
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$327
Neurocrine Biosciences, Inc.
$78
ERBE USA INC
$50
Janssen Pharmaceuticals, Inc
$46
Bayer Healthcare Pharmaceuticals Inc.
$45
AstraZeneca Pharmaceuticals LP
$41
Lilly USA, LLC
$27
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$25
PFIZER INC.
$20
IDORSIA PHARMACEUTICALS US INC
$18
Top 3 companies account for 67.1% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$916
Janssen Pharmaceuticals, Inc
$537
Novo Nordisk Inc
$297
Mylan Specialty L.P.
$271
Boehringer Ingelheim Pharmaceuticals, Inc.
$270
Merck Sharp & Dohme LLC
$228
Amgen Inc.
$215
AstraZeneca Pharmaceuticals LP
$175
Boston Scientific Corporation
$174
Merck Sharp & Dohme Corporation
$167
ITI, Inc.
$156
Novartis Pharmaceuticals Corporation
$155
Edwards Lifesciences Corporation
$150
Astellas Pharma US Inc
$146
Daiichi Sankyo Inc.
$146
Bayer HealthCare Pharmaceuticals Inc.
$142
Neurocrine Biosciences, Inc.
$127
SANOFI PASTEUR INC.
$113
PFIZER INC.
$94
IDORSIA PHARMACEUTICALS US INC
$62
ERBE USA INC
$50
Lilly USA, LLC
$49
Bayer Healthcare Pharmaceuticals Inc.
$45
Nevro Corp.
$44
Almatica Pharma LLC
$41
Abbott Laboratories
$36
Sunovion Pharmaceuticals Inc.
$32
Teva Pharmaceuticals USA, Inc.
$31
Allergan Inc.
$30
Circassia Pharmaceuticals Inc
$30
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$25
Exact Sciences Corporation
$24
SANOFI-AVENTIS U.S. LLC
$23
Shionogi Inc
$22
DEXCOM, INC.
$20
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Top 3 companies account for 34.6% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · ANORO · APTIOM · AREXVY · AUSTEDO · Aimovig · BELSOMRA · BREO · BRILINTA · CAPLYTA · COMIRNATY · Cologuard Collection Kit · Cryo 2 · DEXCOM G6 TRANSMITTER · DUAKLIR PRESSAIR · ELIQUIS · ENTRESTO · EVENITY · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FLUZONE HIGH-DOSE · FreeStyle Libre 2 · GRALISE · INGREZZA · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · Kerendia · MOUNJARO · MYRBETRIQ · NURTEC ODT · OCTRODE · Omnia · Otezla · Ozempic · PRADAXA · Prolia · QUVIVIQ · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SPIRIVA · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO · STIOLTO RESPIMAT · Symproic · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · Tresiba · Utibron · VERQUVO · VRAYLAR · Victoza · WATCHMAN Access System · Wegovy · XARELTO · XIFAXAN · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
68
Per 100K population
3.1
County median income
$82,184
Nearest hospital
HI-DESERT MEDICAL CENTER
8.1 mi
8.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mahajan is a clinical cardiology specialist, with above-average Medicare volume (top 11% in CA), with low-engagement industry engagement in the top 16% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mahajan experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mahajan performed 721 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mahajan receive payments from pharmaceutical companies?
Yes. Dr. Mahajan received a total of $5,059 from 36 companies across 212 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mahajan's costs compare to other internal medicine physicians in Yucca Valley?
Dr. Mahajan's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mahajan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Yucca Valley
Browse internal medicine physicians in Yucca Valley ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology